ALS drug wins FDA approval despite questionable dataU.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig's diseaseSeptember 29, 2022 at 9:26 pm EDT
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/COTSWS4YHRBQY43HU44ZE4T6VM.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/FUPJXIT6QWAEXTYD2V5LQHLN5I.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/CKKN7IJ7U332X3VSEECXCWH2FY.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/WA2CRGXQTFEH6FDWTHDLEO446M.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/O76BLWX4N6KTBZJRRVQCOF5C7Y.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/G33OZLRHVIUTJP6YYYB3TZ63HA.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/JFYU7QNDBJDXART6MJ4FZYQJN4.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/EPHXDXVI3E4UGYJBPUTIJPXRKI.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/QVWYYKBCPUKPBDGA4X3IHH6DCM.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/IMFMS5CVBJCYDJSB2EYKQMLHRQ.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/4EMNNUHSCGEHOITRLBPZROJHPI.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/WGQ4GGD7PU5MWQZU6UYIB3TC3E.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/HBHS4PIWJPJLP4L2BMILJL4TXM.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/SMI5UKAK64JD6N4VT4LATFVMDQ.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/6V53NT4JFET6RTZTXXB7AWKAEA.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/YEXRYDTL2VXS5L4ALD2PMZQKWU.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/2WFLCKOGNVFJFK37SFWITPTMFA.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/2XAP6CGS3DSHYV7QDEZC2K4BKQ.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/7GFZ6354FCHX4MSXI7EITLWGUA.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/PO6WXGT3SLRSUP5HF2C5CAS6VY.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/LIGQGM3NNRCEO5G4EY3OM6CQSY.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/MIVKOHHNN45ZMZP63VTRYJBFSU.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/FH2HD5QVRJVPO2A6KOF2HOOQFE.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/SZZY23A7RK75WDEDT43JP63JY4.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/KHX5A4YCSYPQBZJ6ZONASJF2LM.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/MXAXQ6OXYE54XWRHFUN54RAYUE.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/JD55KOK736BC46MEDJOF7CECSY.jpg)
:quality(70)/d1hfln2sfez66z.cloudfront.net/09-24-2022/t_e237c8d3ea854e4eba8d05927e778199_name_file_960x540_1200_v3_1_.jpg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/LFGOF7BHXVI6LWUMG5UKLE4B5E.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/cmg/7QOJU3BNCJERBNKJC5LWTBYFLU.png)